SCHEMBL13513281

SCHEMBL13513281

CS(=O)(=O)Nc1cccc(CC(N)=O)c1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
POLB P06746 1/20 0.51
NR3C1 P04150 1/20 0.50
ROCK1 Q13464 7/20 0.49
PRKACA P17612 2/20 0.49
CYP3A4 P08684 4/20 0.47
ROCK2 O75116 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
KEAP1 Q14145 1/20 0.46
IKBKB O14920 1/20 0.45
CHUK O15111 1/20 0.45
CSNK2A1 P68400 1/20 0.44
DRD2 P14416 1/20 0.44
DRD4 P21917 1/20 0.44
DRD3 P35462 1/20 0.44
HTR6 P50406 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL27533178 0.98 ALDH1A1 (0.53) ALDH1A1SMN1; SMN2POLBNR3C1ROCK1
SCHEMBL2767758 0.86 ALDH1A1 (0.55) ALDH1A1SMN1; SMN2POLBNR3C1ROCK1
SCHEMBL876253 0.84 NR3C1 (0.47) ALDH1A1SMN1; SMN2POLBNR3C1ROCK1
SCHEMBL843461 0.84 NR3C1 (0.47) ALDH1A1SMN1; SMN2POLBNR3C1ROCK1
SCHEMBL2767849 0.83 POLB (0.57) ALDH1A1SMN1; SMN2POLBNR3C1ROCK1
SCHEMBL15834340 0.83 ROCK1 (0.54) ALDH1A1SMN1; SMN2POLBNR3C1ROCK1
SCHEMBL18722495 0.82 ROCK1 (0.53) ALDH1A1SMN1; SMN2POLBNR3C1ROCK1
SCHEMBL398666 0.81 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2POLBNR3C1ROCK1
SCHEMBL3560306 0.80 IKBKB (0.58) ALDH1A1SMN1; SMN2POLBNR3C1KEAP1
SCHEMBL4149990 0.80 HPGD (0.61) ALDH1A1SMN1; SMN2KEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105102456-B Azaquinazoline inhibitors of atypical protein kinase C 癌症研究技术有限公司 2017-11-14 CN disclosed
CN-105102456-A Azaquinazoline inhibitors of atypical protein kinase C IGNYTA INC 2015-11-25 CN disclosed
EP-1487453-B1 N- ¬(2S)-4-(3,4-DIFLUOROBENZYL)MORPHOLIN-2-YL METHYL -2- 3-¬(METHYLSULPHONYL)AMINO PHENYL ACETAMIDE AS CCR3 ANTAGONIST FOR THE TREATMENT OF INFLAMMATORY CONDITIONS GLAXO GROUP LTD (GB) 2010-01-13 EP disclosed
CN-1678594-A Morpholin-acetamide derivatives for the treatment of inflammatory diseases GLAXO GROUP LTD (GB) 2005-10-05 CN disclosed
CN-1642553-A N-{'(2S) -4- (3, 4-difluorobenzyl) morpholin-2yl!methyl} -2-{3-' (methylsulphonyl) amino! phenyl}acetamide as CCR3 antagonist for the treatment of inflammatory conditions GLAXO GROUP LTD (GB) 2005-07-20 CN disclosed